- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01600664
The Effect of the Use of Computer Game- "My Diabetic Friend" in Children With Type 1 Diabetes
Randomized Controlled Trial to Evaluate the Effect of 3 Months Use With Interactive Computer Game- "My Diabetic Friend"-Comparing to Conventional Diabetes Education on Metabolic Control, Quality of Life and Diabetes Knowledge in Children With Type 1 Diabetes.
A randomized controlled study to evaluate the effect of 3 months use with interactive computer game- "My Diabetic Friend"- comparing to conventional diabetes education on metabolic control, quality of life and diabetes knowledge.Patients will be randomized into two groups- one group will be supplied with interactive computer game, "My Diabetic friend", installed on a computer designed for children's educational needs for a period of three months and the other group will be supplied with the same computer without the interactive computer game for three months. Metabolic control, quality of life and diabetes knowledge will be evaluated before and after the use of the computer.
The trial is consisting of two main periods: 3 months of the main study period and an optional extension period consisting of the following 3 months :
The study will include two main periods;
- Period 1 which will last 3 months, in a randomized controlled manner, this period will serve as the main study period to assess the primary and secondary endpoints of the study.
- Period 2: this extension period will not be an integral part of the study, and only patients who are willing will take part at this period, will continue to participate at the optional extension period. During the extension period, patients in the intervention group will be offered to continue the use of the Computer game -"My diabetic friend) for the following 3 months, and patients who participated at the control group during period 1, will be offered to start to use the Computer Game - "My Diabetic Friend" for the following 3 months.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Petach- Tikva, Israel
- Schneider Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Type 1 diabetes diagnosed at least one year prior to study entry.
- Age:7-11 years old.
- Treatment either with CSII or MDI.
- HbA1c>8.0%
- Signing an informed consent form.
Exclusion Criteria:
- Any significant disease or conditions, including psychiatric disorders that in the opinion of the investigator are likely to affect subject compliance or subject's ability to complete the study.
- Inability to understand/ complete the questionnaires.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: interactive computer game
Participants will be using the interactive computer game- "My Diabetic Friend", installed on Intel-powered convertible classmate PC.
|
Participants will use the interactive computer game installed on a convertible PC
|
Active Comparator: Convertible PC
Participants will be using the convertible classmate PC without the interactive computer game
|
Participants will be using the convertible PC without the interactive computer game
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of life
Time Frame: After 12 weeks (end of study)
|
Quality of life questionnaires will be completed
|
After 12 weeks (end of study)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Metabolic control
Time Frame: After 12 weeks (end of study)
|
HbA1c will be measured
|
After 12 weeks (end of study)
|
Diabetes knowledge
Time Frame: After 12 weeks
|
Diabetes knowledge questionnaires will be completed
|
After 12 weeks
|
Patient's gaming duration
Time Frame: After 12 weeks
|
The frequency and the duration of use of the interactive computer game by each participant will be monitored by the study team
|
After 12 weeks
|
Compliance to diabetes treatment
Time Frame: After 12 weeks
|
Patient's parents will undergo clinical interview about patient's diabetes adherence
|
After 12 weeks
|
Average glucose levels
Time Frame: After 12 weeks (end of study)
|
After 12 weeks (end of study)
|
|
Average number of blood glucose measurements
Time Frame: After 12 weeks (end of study)
|
After 12 weeks (end of study)
|
|
Measurements within normal range
Time Frame: After 12 weeks (end of study)
|
After 12 weeks (end of study)
|
|
Hypoglycemia events
Time Frame: After 12 weeks (end of study)
|
After 12 weeks (end of study)
|
|
Hyperglycemia events
Time Frame: After 12 weeks (end of study)
|
After 12 weeks (end of study)
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- rmc006814ctil
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Type 1 Diabetes
-
Poznan University of Medical SciencesUnknownDiabetes Mellitus Type 1 | Remission of Type 1 Diabetes | Chronic Complications of DiabetesPoland
-
Eledon PharmaceuticalsWithdrawnBrittle Type 1 Diabetes MellitusUnited States
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)CompletedType 1 Diabetes Mellitus | T1DM | T1D | New-onset Type 1 Diabetes MellitusUnited States, Australia
-
Hoffmann-La RocheCompletedType 2 Diabetes, Type 1 DiabetesAustria, United Kingdom
-
Shanghai Changzheng HospitalRecruitingBrittle Type 1 Diabetes MellitusChina
-
Capillary Biomedical, Inc.TerminatedType 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Type I | Diabetes Mellitus, Insulin-Dependent, 1 | IDDMAustria
-
Capillary Biomedical, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Type 1 Diabetes Mellitus | Diabetes Mellitus, Insulin-Dependent, 1Australia
-
AstraZenecaCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
NYU Langone HealthNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
Rabin Medical CenterDreaMed DiabetesTerminated
Clinical Trials on Interactive computer game
-
Medical University of South CarolinaUniversity of DelawareCompleted
-
Hadassah Medical OrganizationUnknownExamining an Emergency Room Intervention for the Prevention of Post Traumatic Stress Disorder (PTSD)Posttraumatic Stress DisorderIsrael
-
Penn State UniversityNational Institute of Mental Health (NIMH)CompletedAutismUnited States
-
University at BuffaloTerminatedStudy Individuals' Activity Choices After Playing a Computer GameUnited States
-
National Taiwan University HospitalCompletedPain | Hospitalism in ChildrenTaiwan
-
The University of Hong KongChinese University of Hong Kong; The Hong Kong Polytechnic University; Hong Kong... and other collaboratorsCompleted
-
The Hong Kong Polytechnic UniversityCompleted
-
University Hospital, Basel, SwitzerlandCompleted
-
National Cheng Kung UniversityUnknownEffects of Cognitive Strategy Training on Daily Function in People With Subjective Cognitive DeclineSubjective Cognitive DeclineTaiwan
-
York UniversityCanadian Institutes of Health Research (CIHR); North York General HospitalCompletedMental Health DisordersCanada